首页> 外国专利> COMPOUNDS FOR TREATING DENGUE VIRUS INFECTION AND OTHER VIRAL INFECTIONS

COMPOUNDS FOR TREATING DENGUE VIRUS INFECTION AND OTHER VIRAL INFECTIONS

机译:用于治疗登革热病毒感染和其他病毒感染的化合物

摘要

International Patent Classification: C07D 209/30 (2006.01) C07D 209/42 (2006.01) (21) International Application Number: PCT/US2018/032849 (22) International Filing Date: 15 May 2018 (15.05.2018) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 62/506,588 15 May 2017 (15.05.2017) US (71) Applicants: DANA-FARBER CANCER INSTITUTE, INC. [US/US]; 450 Brookline Avenue, Boston, MA 02215 (US). PRESIDENT AND FELLOWS OF HARVARD COLLEGE [US/US]; 17 Quincy Street, Cambridge, MA 02138 (US). (72) Inventors: YANG, Priscilla, L.; 26 Greenview Avenue, Boston, MA 02130 (US). LIAN, Wenlong, L.; 155 Strath- more Road, Apt. #1, Boston, MA 02135 (US). GRAY, Nathanael, S.; 26 Greenview Avenue, Boston, MA 02130 (US). KWIATKOWSKI, Nicholas, Paul; 12 Kilsyth Road, #2, Brookline, MA 02445 (US). WANG, Jinhua; 103 Loring Avenue, Winchester, MA 01890 (US). JANG, Jaebong; 521 Heath Street, Brookline, MA 02467 (US). (74) Agent: ZHANG, Wei; Wolf, Greenfield & Sacks, P.C., 600 Atlantic Avenue, Boston, MA 02210-2206 (US). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, (54) Title: COMPOUNDS FOR TREATING DENGUE VIRUS INFECTION AND OTHER VIRAL INFECTIONS + compound, co- 0V2 NGC M01=1 Remove inoculum, wash and add Pre-incubation incubation fresh media 1 4 , 1 -45 min 0 1 h Figure 2A 6x113 5 4x10 5 .4 0ta DV2 NGC M01=1 E ▪ 2x10 5- -2 -1 0 log[K786-9730]/01 K786-0739 -2x10 5 RC Y Single-cycle yield by plaque formation assay 4 24 h 00 O O (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 22 November 2018 (22.11.2018) WIP01 PCT oimitia °nolo Holoffinonuno oimIE (10) International Publication Number WO 2018/213365 Al (57) : The present disclosure provides antiviral (e.g., anti -Dengue virus) agents, such as compounds of Formula (I). Also provided are pharmaceutical compositions and kits of the compounds of Formula (I). Further provided are methods and uses of the antiviral agents (e.g., the compounds of Formula (I); and compounds K786-9739, S4105, C200-5340, G199-0398, C200-9144, S7337, S1633, and C066-4182, and derivatives thereof) for treating or preventing a viral infection Dengue fever). The antiviral agents (e.g., may inhibit the entry of a virus into a cell by, e.g., inhibiting the fusion between the envelope of the virus and the membrane of the cell. [Continued on next page] WO 2018/213365 Al MIDEDIM011111 11111111E1010010E11111101111111101111111111111111111 TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Published: — with international search report (Art. 21(3))
机译:国际专利分类:C07D 209/30(2006.01)C07D 209/42(2006.01)(21)国际申请号:PCT / US2018 / 032849(22)国际申请日期:2018年5月15日(15.05.2018)(25)申请语言:英语(26)出版语言:英语(30)优先数据:62 / 506,588 2017年5月15日(2017年5月15日)美国(71)申请人:DANA-FARBER CANCER INSTITUTE,INC。[美国/美国]; 450 Brookline Avenue,Boston,MA 02215(US)。哈佛大学的院长和同胞[美国/美国]; 17 Quincy Street,Cambridge,MA 02138(US)。 (72)发明人:YANG,Priscilla,L .; 26 Greenview Avenue,Boston,MA 02130(US)。廉文龙公寓地址:Strath-more Road 155。 #1,波士顿,马萨诸塞州02135(美国)。灰色,Nathanael,S .; 26 Greenview Avenue,Boston,MA 02130(US)。 KWIATKOWSKI,尼古拉斯·保罗; 12 Kilsyth Road,#2,Brookline,MA 02445(US)。王金华103 Loring Avenue,Winchester,MA 01890(US)。张载丰521 Heath Street,Brookline,MA 02467(US)。 (74)代理人:张伟;沃尔夫,格林菲尔德和萨克斯(P.C.),位于马萨诸塞州波士顿市大西洋大道600号,马萨诸塞州02210-2206。 (81)指定国家(除非另有说明,对于每种可用的国家保护):AE,AG,AL,AM,AO,AT,AU,AZ,BA,BB,BG,BH,BN,BR,BW,BY ,BZ,CA,CH,CL,CN,CO,CR,CU,CZ,DE,DJ,DK,DM,DO,DZ,EC,EE,EG,ES,FI,GB,GD,GE,GH,GM ,GT,HN,HR,HU,ID,IL,IN,IR,IS,JO,JP,KE,KG,KH,KN,KP,KR,KW,KZ,LA,LC,LK,LR,LS,LU ,LY,MA,MD,ME,MG,MK,MN,MW,MX,MY,MZ,NA,NG,NI,NO,NZ,OM,PA,PE,PG,PH,PL,PT,QA,RO ,RS,RU,RW,SA,SC,SD,SE,SG,SK,SL,SM,ST,SV,SY,TH,TJ,TM,TN,TR,TT,TZ,UA,UG,US,UZ ,VC,VN,ZA,ZM,ZW。 (84)指定国家(除非另有说明,对于每种可用的区域保护):ARIPO(BW,GH,GM,KE,LR,LS,MW,MZ,NA,RW,SD,SL,ST,SZ,TZ ,UG,ZM,ZW),欧亚(AM,AZ,BY,KG,KZ,RU,TJ,TM),欧洲(AL,AT,BE,BG,CH,CY,CZ,DE,DK,EE,ES ,FI,FR,GB,GR,HR,HU,IE,IS,IS,IT,LT,LU,LV,MC,MK,MT,NL,NO,PL,PT,RO,RS,SE,SI,SI,SK,SM ,(54)标题:用于治疗登革热病毒感染和其他病毒感染的化合物+化合物,共0V2 NGC M01 = 1取出接种物,洗涤并添加预孵育的新鲜培养基1 4,1 -45 min 0 1 h图2A 6x113 5 4x10 5 .4 0ta DV2 NGC M01 = 1 E▪2x10 5- -2 -1 0 log [K786-9730] / 01 K786-0739 -2x10 5 RC Y通过噬菌斑形成测定的单周期产量4 24 h 00面向对象的(12)根据专利合作条约(PCT)公布的国际申请(19)世界知识产权组织国际局(43)国际公开日期2018年11月22日(22.11.2018)WIP01 PCT国际标准化组织oimitia°nolo Holoffinon (10)国际公开号WO 2018/213365 A1(57):本公开提供了抗病毒剂(例如抗登革热病毒),例如式(I)的化合物。还提供了式(I)化合物的药物组合物和试剂盒。还提供了抗病毒剂(例如式(I)的化合物;以及化合物K786-9739,S4105,C200-5340,G199-0398,C200-9144,S7337,S1633和C066-4182,及其衍生物)用于治疗或预防病毒感染登革热)。抗病毒剂(例如,可以通过例如抑制病毒的包膜和细胞膜之间的融合来抑制病毒进入细胞。[续下页] WO 2018/213365 A1 MIDEDIM011111 11111111E1010010E11111101111111101101111111111111111111111 TR ),OAPI(BF,BJ,CF,CG,CI,CM,GA,GN,GQ,GW,KM,ML,MR,NE,SN,TD,TG)。发布:—附国际检索报告(第21条第3款)

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号